References
- Austria R, Semenzato A, Bettero A. Stability of vitamin C derivatives in solution and topical formulations. J Pharm Biomed Anal 1997; 15: 795–801
- Bunjes H, Koch MHJ, Westesen K. Effect of particles size on colloidal solid triglycerides. Langmuir 2000; 16: 5234–5241
- Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm 2002; 238: 241–245
- Dingler A, Blum RP, Niehus H, Müller RH, Gohla S. Solid lipid nanoparticles (SLN/Lipopearls)—a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products. J Microencapsulation 1999; 16: 751–767
- Dingler A, Krohs S, Lukowski G, Gohla S, Müller RH. SLN (Solid Lipid Nanoparticles) as new solid carrier of active ingredients in cosmetics. Eur Jf Pharm Sci 1996; 4: S148
- Fukushima S, Takahashi M, Yamaguchi M. Effect of cetostearyl alcohol on stabilization of oil-in-water emulsion. J Colloid Interface Sci 1976; 57: 201–206
- Fundaro A, Cavalli R, Bargoni A, Vighetto D, Zara GP, Gasco MR. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. Pharmacol Res 2000; 42: 337–343
- Hu FQ, Hong Y, Yuan H. Preparation and characterization of solid lipid nanoparticles containing peptide. Int J Pharm 2004; 273: 29–35
- Hu FQ, Jiang S-P, Du Y-Z, Yuan H, Ye Y-Q, Zeng S. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surfaces B: Biointerfaces 2005; 45: 167–173
- Jenning V, Gysler A, Schäfer-Korting M, Gohla SH. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 2000a; 49: 211–218
- Jenning V, Schäfer-Korting M, Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Control Rel 2000b; 66: 115–126
- Kristl J, Volk B, Gašperlin M, Sentjurč M, Jurkovic P. Effect of colloidal carriers on ascorbyl palmitate stability. Eur J Pharm Sci 2003; 19: 181–189
- Lim S-J, Lee M-K, Kim C-K. Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J Control Rel 2004; 100: 53–61
- Lippacher A, Müller RH, Mäder K. Investigation on the viscoelastic properties of lipid based colloidal drug carriers. Journal of Microencapsulation 2000; 196: 227–230
- Lippacher A, Müller RH, Mäder K. Semi-solid SLN(TM) dispersions for topical application: Influence of formulation and production parameters on viscoelastic properties. Eur J Pharm Biopharm 2002; 53: 155–160
- Lippacher A, Müller RH, Mäder K. Liquid and semi-solid SLN(TM) dispersions for topical application: Rheological characterization. Eur J Pharm Biopharm 2004; 58: 561–567
- Maia CS, Mehnert W, Schäfer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharm 2000; 196: 165–167
- Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001; 47: 165–196
- Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur J Pharm Biopharm 2000; 50: 161–177
- Müller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002a; 242: 121–128
- Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002b; 54: S131–S155
- Saupe A, Gordon KC, Rades T. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. Int J Pharm 2006; 314: 56–62
- Sivaramakrishnan R, Nakamura C, Mehnert W, Korting HC, Kramer KD, Schäfer-Korting M. Glucocorticoid entrapment into lipid carriers—characterisation by parelectric spectroscopy and influence on dermal uptake. J Control Rel 2004; 97: 493–502
- Souto EB, Anselmi C, Centini M, Müller RH. Preparation and characterization of n-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN®). Int J Pharm 2005; 295: 261–268
- Souto EB, Müller RH. SLN and NLC for topical delivery of ketoconazole. J Microencapsulation 2005; 22: 501–510
- Souto EB, Wissing SA, Barbosa CM, Müller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004a; 278: 71–77
- Souto EB, Wissing SA, Barbosa CM, Müller RH. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur J Pharm Biopharm 2004b; 58: 83–90
- Špiclin P, Gašperlin M, Kmetec V. Stability of ascorbyl palmitate in topical microemulsions. Int J Pharm 2001; 222: 271–279
- Üner M, Wissing SA, Yener G, Müller RH. Solid lipid nanoparticles (SLN) and nanostrutured lipid carriers (NLC) for application of ascorbyl palmitate. Pharmazie 2005; 60: 577–582
- Westesen K, Bunjes H. Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix?. Int J Pharm 1995; 115: 129–131
- Wissing SA, Müller RH. The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int J Pharm 2002a; 242: 377–379
- Wissing SA, Müller RH. Solid lipid nanoparticles as carrier for sunscreens: In vitro release and in vivo skin penetration. J Control Rel 2002b; 81: 225–233
- Wissing SA, Müller RH. Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm 2003a; 254: 65–68
- Wissing SA, Müller RH. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity—in vivo study. Eur J Pharm Biopharm 2003b; 56: 67–72
- Wissing SA, Müller RH, Manthei L, Mayer C. Structural characterization of Q10-loaded solid lipid nanoparticles by NMR spectroscopy. Pharm Res 2004; 21: 400–405
- Zimmermann E, Souto EB, Müller RH. Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticle (SLN™) by means of DSC and 1H NMR. Pharmazie 2005; 60: 508–513
- zur Mühlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery—drug release and release mechanism. Eur J Pharm Biopharm 1998; 45: 149–155
- zur Mühlen A, zur Mühlen E, Niehus H, Mehnert W. Atomic force microscopy studies of solid lipid nanoparticles. Pharm Res 1994; 13: 1411–1416